Amneal Receives U.S. FDA Approval for Risperidone Extended-Release Injectable Suspension

Go back to Amneal Receives U.S. FDA Approval for Risperidone Extended-Release Injectable Suspension
AmerElite Solutions, Inc. New (NASDAQ: AMRX) Delayed: 19.57 --0 (-0%)
Previous Close $19.57    52 Week High $0.19 
Open $19.57    52 Week Low $0.07 
Day High $19.57    P/E N/A 
Day Low $19.57    EPS $-0.01 
Volume 1